United States · Investor

Boston Millennia Partners

Last cheque observed Feb 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $12M, May 2023Private equity

SeedSeries ASeries BWellbeingHealthcareTelehealth

Cheques on record
0%of best year0cheques in 12 months, 42 on record
Since the last cheque3169days00hrs00min00sec
Median round$18MRounds led0 of 42Sole investor3 roundsExits11 from the portfolioMostly inUnited States, 100%
Pitch Boston Millennia Partners

Boston Millennia Partners highlights

  1. 01

    42 rounds on record

  2. 02

    Mostly Series C and Venture: 57% of its rounds

  3. 03

    Sole investor in 3 rounds, median $11M

  4. 04

    11 exits from the portfolio

What they do

Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
WellbeingHealthcareTelehealth
Based in
Boston, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first42 appearances

  1. 2018

    1 round

  2. Feb
    CotaSeries C · US · FinSMEs$40MWith 4 others
  3. 2017

    1 round

  4. Mar
    BivarusSeries B · US · FinSMEs$4.0MWith 2 others
  5. 2016

    1 round

  6. Dec
    CotaUS · FinSMEs$18MWith 2 others
  7. 2015

    2 rounds

  8. Jun
    Avhana HealthSeed · US$750KWith 4 others
  9. Mar
    Collegium PharmaceuticalVenture · US$50MWith 10 others
  10. 2013

    1 round

  11. Sept
    PreCision DermatologyDebt · US · pehub.com$67MWith 7 others
  12. 2010

    2 rounds

  13. Dec
    SensorLogicVenture · US · sensorlogic.com$5.0MWith 3 others
  14. Oct
    NexidiaSeries F · US · businesswire.com$23MWith 7 others
  15. 2009

    3 rounds

  16. Dec
    Coapt SystemsDebt · US · deals.venturebeat.com$3.7MWith 7 others
  17. Oct
    CardioMEMSSeries F · US · onbiovc.com$22MWith 9 others
  18. Mar
    MedAptusVenture · US · medaptus.com$6.0MSole investor
  19. 2008

    3 rounds

  20. Sept
    HistogenicsSeries B · US · equityhelpdesk.com$13MWith 1 other
  21. Jul
    Collegium PharmaceuticalSeries D · US$20MWith 2 others
  22. Apr
    SensorLogicSeries C · US$9.0MWith 5 others
  23. 2007

    4 rounds

  24. Dec
    CardioMEMSSeries E · US$33MWith 1 other
  25. Nov
    InfotrieveSeries C · US · infotrieve.com$5.0MWith 2 others
  26. Jun
    SensorLogicSeries B · US · millenniapartners.com$5.0MWith 5 others
  27. Mar
    Coapt SystemsSeries E · US · deals.venturebeat.com$23MWith 6 others
  28. 2006

    4 rounds

  29. Nov
    CardioMEMSSeries D · US$23MWith 4 others
  30. Nov
    Collegium PharmaceuticalSeries C · US$5.5MWith 1 other
  31. Aug
    NexidiaVenture · US · nexidia.com$13MWith 5 others
  32. Jan
    AthenixSeries C · US · athenixcorp.com$13MWith 5 others
  33. 2005

    3 rounds

  34. Mar
    Netifice CommunicationsVenture · US$55MWith 5 others
  35. Feb
    ArthrosurfaceSeries D · US$11MSole investor
  36. Jan
    Predix PharmaceuticalsSeries C$43MWith 10 others
  37. 2004

    6 rounds

  38. Sept
    SensorLogicSeries A · US$11MSole investor
  39. Jun
    RejuvenonSeries B · US$37MWith 5 others
  40. Apr
    Continuum PhotonicsSeries C · US$18MWith 5 others
  41. Mar
    ZalicusSeries C · US$30MWith 6 others
  42. Jan
    AthenixSeries B · US · millenniapartners.com$13MWith 5 others
  43. Jan
    InfotrieveSeries B · US$22MWith 2 others
  44. 2003

    5 rounds

  45. Nov
    CardioMEMSSeries B · US$14MWith 4 others
  46. Nov
    Protein ForestSeries A · US$19MWith 3 others
  47. Sept
    Odyssey Logistics & TechnologyVenture · US$24MWith 3 others
  48. Jul
    EntigoVenture$3.0MWith 5 others
  49. Feb
    FHP WirelessSeries C · US$8.3MWith 3 others
  50. 2002

    1 round

  51. Aug
    NuVoxGrowth · US$79MWith 9 others
  52. 2001

    2 rounds

  53. Oct
    Protonex Technology CorporationSeries C · US$90MWith 4 others
  54. Sept
    AthenixSeries A · US · athenixcorp.com$8.0MWith 2 others
  55. 2000

    2 rounds

  56. Jun
    NewWorld CommunicationsVenture$150MWith 10 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

ADA. Dana CallowPresident, Managing General PartneriForm ADV
BRBruce R. TiedemannChief Financial OfficeriForm ADV
MJMartin J. HernonVice President, Chief Compliance Officer, General PartneriForm ADV

We also hold 12 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$24Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
GLEN Ventures Managment, INC
SEC number
CRD 162789

Exits from the portfolio

Companies it backed that were later bought or listed11 in all

Protonex Technology CorporationBought by Ballard Power Systems$30MJun 2015
InfotrieveBought by Copyright Clearance Center$17MNov 2014
PreCision DermatologyBought by Valeant Pharmaceuticals International$500MFeb 2014
SensorLogicBought by GemaltoUndisclosedDec 2011
Coapt SystemsBought by MicroAireUndisclosedAug 2010
Protein ForestBought by CellBiosciencesUndisclosedDec 2009
NuVoxBought by Windstream$643MNov 2009
AthenixBought by Bayer CropScienceUndisclosedAug 2009
CardioMEMSBought by St. Jude MedicalUndisclosedNov 2003
Quintessent CommunicationsBought by AMS-CGIUndisclosedJan 2003

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Boston Millennia Partners. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Boston Millennia Partners put money into.

Quick answers about Boston Millennia Partners

What does Boston Millennia Partners invest in?

Boston Millennia Partners invests most often at Series C and Venture (57% of the rounds on record), in sectors such as Wellbeing, Healthcare and Telehealth.

How active is Boston Millennia Partners?

42 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2018.

What has Boston Millennia Partners invested in recently?

Its most recent investments on record: Cota (Series C, Feb 2018) and Bivarus (Series B, Mar 2017).

How big are Boston Millennia Partners's cheques?

The median round it joins is $18M.

Does Boston Millennia Partners lead rounds?

Rarely, if at all: none of its 42 investments on record names it as the lead.

Where does Boston Millennia Partners invest?

Most of the companies it backs are in the United States (100%).

Is Boston Millennia Partners investing now?

No investments in the last 12 months; the latest was in Feb 2018.

Who does Boston Millennia Partners invest alongside?

Most often Covera Ventures (5 rounds together), Easton Capital (5 rounds together) and Foundation Medical Partners (4 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it